Skip to content Skip to sidebar Skip to footer

Addressing Nonventilator Hospital-Acquired Pneumonia: An Examination of ECRI’s Rapid Review and Prevention Strategies

Nonventilator hospital-acquired pneumonia (NV-HAP) represents a significant health threat, accounting for around 60% of all hospital-acquired pneumonia instances. Notably, NV-HAP ranks among the most prevalent healthcare-associated infections and has been linked to considerable health complications as well as escalated healthcare expenses. A lack of a standardized definition and wider reporting in national surveillance systems makes…

Read more

Fending Off the Threat of Clostridium Difficile Infections: A Comprehensive Guide for Healthcare Professionals

Clostridium difficile infection (CDI), colloquially known as C. diff, represents one of the primary causes of hospital-acquired infections and commonly triggers mortality among older, hospitalized adults. As elucidated by Dr. Raghavendra Tirupathi, a Medical Director at Keystone Infectious Diseases, alongside his medical student assemblage, a profound understanding of Clostridium difficile is central to infection prevention…

Read more

Comprehensive Strategies for the Prevention of Hospital-Acquired Pneumonia

Nonventilator hospital-acquired pneumonia (NV-HAP) is one of the most prevalent and deadly hospital-acquired infections (HAI) and significantly affects patient outcomes. Findings from a 2023 study conducted in 284 US hospitals revealed that NV-HAP contributed to 1 in 14 hospital deaths, posing an inpatient mortality rate of 22.4%. Furthermore, NV-HAP was linked to substantial morbidity and…

Read more

Exploring the Promising Role of Nirsevimab in Mitigating Pediatric ICU Admissions Due to RSV Infections: A Study Overview

A study recently published in the open-access medical journal, JAMA Network Open, suggests a potential link between the implementation of Respiratory Syncytial Virus (RSV) prevention strategies, like the maternal RSV vaccine and Nirsevimab, and a decrease in intensive care unit (ICU) admissions for pediatric patients. This multicenter, retrospective cross-sectional study was the product of substantial…

Read more

The Imperative Role of Infection Preventionists in the Fight Against Drug Diversion

Wolters Kluwer, a recognized leader in presenting information on healthcare, legal, tax and accounting, corporate compliance, and ESG has underlined the significance of trusted clinical technology and evidence-based solutions crucial in decision-making and outcome generation within healthcare. They emphasize on clinical effectiveness, learning, research, and safety. Businesses vary in size and professional needs and Wolters…

Read more

The Unfolding Quest against Mpox Outbreak: Insights from BlueDot Global

Andrea Thomas and Mariana Torres Portillo, both reputable figures from the infectious disease surveillance company, BlueDot Global, have recently shared intriguing insights about the mpox outbreak. With Thomas as the Director of Epidemiology and Portillo as the Infectious Disease Surveillance Manager at BlueDot Global, they recently discussed this significant public health concern during a webinar. The…

Read more

Sign Up to Our Newsletter

Be the first to know the latest updates

[yikes-mailchimp form="1"]